Geneva Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,258,671
| Closed | -$21.3M | – | 128 |
|
|
2023
Q3 | $21.3M | Sell |
2,258,671
-61,299
| -3% | -$579K | 0.45% | 72 |
|
|
2023
Q2 | $32.4M | Sell |
2,319,970
-5,939
| -0.3% | -$83K | 0.64% | 59 |
|
|
2023
Q1 | $43.6M | Buy |
2,325,909
+489,128
| +27% | +$9.18M | 0.89% | 46 |
|
|
2022
Q4 | $25.3M | Buy |
1,836,781
+396,417
| +28% | +$5.46M | 0.57% | 66 |
|
|
2022
Q3 | $27.5M | Buy |
1,440,364
+74,014
| +5% | +$1.42M | 0.64% | 62 |
|
|
2022
Q2 | $20.9M | Sell |
1,366,350
-24,840
| -2% | -$379K | 0.48% | 82 |
|
|
2022
Q1 | $28.3M | Buy |
+1,391,190
| New | +$28.3M | 0.55% | 76 |
|